Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


Effectiveness of obeticolic acid in primary biliary cholangitis patients in a tertiary hospital

  • At: Virtual 2020 (2020)
  • Type: Poster
  • Poster code: POS-HPS-039
  • By: ROGADO VEGAS, Berta (Hospital Universitario Marqués de Valdecilla, Servicio de Farmacia, Spain)
  • Co-author(s): Berta Rogado Vegas: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Julia Sanchez Gundín: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Carlos Alonso Peralta: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Rosa Maria Gonzalez Franco: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Maria Rioja Carrera: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Paula Del Rio Ortega: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Marta Valero Dominguez: Servicio de Farmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain
  • Abstract:

    Background

    Obeticholic acid is a semi-synthetic bile acid analogue. It is used as a drug to treat primary biliary cholangitis (PBC).

    Purpose

    To evaluate the effectiveness of obeticolic acid in PBC patients at 48 weeks of treatment.

    Methods

    Observational, retrospective study in a third level hospital, including all patients treated with obeticolic

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses